CIK 0000078003 · Pharmaceutical Preparations (SIC 2834) · NYSE · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | |
|---|---|---|
| Revenue (USD) | 62.6 B | 101.2 B |
| Net income (USD) | 7.8 B | 31.4 B |
| Diluted EPS (USD/shares) | 1.36 | 5.47 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-16 | 4 | 4 | 2026-10-15 |
| 2026-10-16 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-10-14 | 4 | 4 | 2026-10-13 |
| 2026-10-01 | 4 | 4 | 2026-09-30 |
| 2026-09-29 | 4 | 4 | 2026-09-25 |
| 2026-09-29 | 4 | 4 | 2026-09-25 |
| 2026-09-29 | 4 | 4 | 2026-09-25 |
| 2026-09-29 | 4 | 4 | 2026-09-25 |
| 2026-09-29 | 4 | 4 | 2026-09-25 |
| 2026-09-29 | 4 | 4 | 2026-09-25 |
| 2026-09-16 | 4 | 4 | 2026-09-15 |
| 2026-09-01 | 4 | 4 | 2026-08-31 |
| 2026-08-31 | N-PX | N-PX | 2026-06-30 |
| 2026-08-28 | 3 | 3 | 2026-08-17 |
| 2026-08-17 | 4 | 4 | 2026-08-14 |
| 2026-08-13 | 13F-HR | 13F-HR | 2026-06-30 |
| 2026-08-12 | 4 | 4 | 2026-08-12 |
| 2026-08-06 | 4 | 4 | 2026-08-05 |
| 2026-08-05 | 4 | 4 | 2026-08-05 |
| 2026-08-05 | 4 | 4 | 2026-08-05 |
| 2026-08-04 | 10-Q | 10-Q | 2026-06-28 |
| 2026-08-04 | 8-K | 8-K items 2.02,9.01 | 2026-08-04 |
| 2026-08-03 | 4 | 4 | 2026-07-31 |
| 2026-07-16 | 4 | 4 | 2026-07-15 |
| 2026-07-13 | 4 | 4 | 2026-07-09 |
Forms on file (last 1,000): 4 717, 8-K 59, DEFA14A 26, SC 13G/A 25, SC 13D/A 21, 10-Q 17, 3 14, 11-K 13. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=PFE (0.002 USD), /gw/filings/filings?ticker=PFE&form=8-K, /gw/filings/facts?ticker=PFE&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange